PNEUMOCOCCAL IMMUNIZATION
Clinical trials for PNEUMOCOCCAL IMMUNIZATION explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCOCCAL IMMUNIZATION trials appear
Sign up with your email to follow new studies for PNEUMOCOCCAL IMMUNIZATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Super-Vaccine aims to protect babies from more Pneumonia-Causing germs
⭐️ VACCINE ⭐️ OngoingThis study is testing a new vaccine designed to protect infants and toddlers from 21 strains of pneumococcal bacteria, which can cause serious infections like pneumonia and meningitis. It will compare the new vaccine's safety and ability to trigger an immune response to an alread…
Matched conditions: PNEUMOCOCCAL IMMUNIZATION
Phase: PHASE3 • Sponsor: Sanofi • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:31 UTC
-
New vaccine schedule tested to protect babies from pneumococcal disease
⭐️ VACCINE ⭐️ OngoingThis study is testing whether a new 21-valent pneumococcal vaccine is safe and helps babies build immunity when given after one or more doses of an existing 20-valent vaccine. It will involve about 580 healthy infants and toddlers, who will receive the vaccines as part of their r…
Matched conditions: PNEUMOCOCCAL IMMUNIZATION
Phase: PHASE3 • Sponsor: Sanofi • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:30 UTC
-
New Super-Vaccine for babies aims to block more pneumonia strains
⭐️ VACCINE ⭐️ OngoingThis study is testing a new version of a vaccine that protects against serious bacterial infections like pneumonia and meningitis. It will compare the new 21-strain vaccine against a currently licensed 20-strain vaccine in about 1,700 healthy infants. The goal is to see if the ne…
Matched conditions: PNEUMOCOCCAL IMMUNIZATION
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:29 UTC